What is PTC Therapeutics's price / earnings?

PTC Therapeutics (PTCT) reported price / earnings of 6.5× in Q3 2025.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

PTC Therapeutics PTCT Price / earnings

Price / earnings at other companies

BioMarin PharmaceuticalsBMRN

20×-21.5×

ALN

Alnylam PharmaceuticalsALNY

87.4×—

Arrowhead ResearchARWR

44.6×—

United TherapeuticsUTHR

20.2×+8.8×

BiogenBIIB

18.9×+5.4×

Protagonist TherapeuticsPTGX

90×—

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

market cap/net income=6.5×

Based on the most recent quarter.

The official record: PTC Therapeutics’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's price / earnings?: PTC Therapeutics (PTCT) reported price / earnings of 6.5× in Q3 2025.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.